| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |